Arkolith/Insider Trading/ZBIO/Form 4

Enright Patrick G

DirectorZenas BioPharma, Inc. (ZBIO) · full profile →Form 4 · filed Oct 14, 2025
Net Buying
Open-Market Buys
$2.3M
Open-Market Sells
$0
Net Open-Market Flow
$2.3M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 9, 2025Buy(P)105K$19.00$2.0M1.8M
Oct 9, 2025Buy(P)12K$20.85$250K12K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-238326) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML